Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2009 Nov 10:23–45. doi: 10.1007/978-3-7643-9912-2_2

Mechanisms of symptoms of common cold and flu

Ronald Eccles ‡
Editors: Ronald Eccles4, Olaf Weber5
PMCID: PMC7122998

Abstract

It is the familiar symptoms of sore throat, runny nose, sneezing, and nasal congestion, muscle aches, chilliness and fever, etc., that define the common cold and flu syndromes as self-diagnosed illnesses. Although there is much information about the molecular biology of the viruses that cause the common cold and flu syndromes, there is relatively little research on the immunological, physiological and pathophysiological mechanisms involved in generating the symptoms. This chapter studies the mechanisms that cause local symptoms associated with local inflammation of the airway (sore throat, sneezing, rhinorrhoea and purulent nasal discharge, nasal congestion, sinus pain, watery eyes and cough), and the mechanisms that cause systemic symptoms associated with release of cytokines from leukocytes (headache, chilliness and fever, psychological effects, malaise and mood changes, loss of appetite, and muscle aches and pains).

Keywords: Sore Throat, Common Cold, Nasal Congestion, Nasolacrimal Duct, Sickness Behaviour

References

  • 1.Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5:718–725. doi: 10.1016/S1473-3099(05)70270-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jackson G., Dowling H., Spiesman I., Boand A. Transmission of the common cold to volunteers under controlled conditions. 1. The common cold as a clinical entity. Arch Intern Med. 1958;101:267–278. doi: 10.1001/archinte.1958.00260140099015. [DOI] [PubMed] [Google Scholar]
  • 3.Heikkinen T., Jarvinen A. The common cold. Lancet. 2003;361:51–59. doi: 10.1016/S0140-6736(03)12162-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tyrrell D.A., Cohen S., Schlarb J.E. Signs and symptoms in common colds. Epidemiol Infect. 1993;111:143–156. doi: 10.1017/S0950268800056764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Monto A.S., Gravenstein S., Elliott M., Colopy M., Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Inter Med. 2000;160:3243–3247. doi: 10.1001/archinte.160.21.3243. [DOI] [PubMed] [Google Scholar]
  • 6.Schmid-Hempel P. Immune defence, parasite evasion strategies and their relevance for ‘macroscopic phenomena’ such as virulence. Philos Trans R Soc Lond. 2009;364:85–98. doi: 10.1098/rstb.2008.0157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Winther B, Farr B, Turner RB, Hendley JO, Gwaltney JM, Mygind N. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol. 1984;413:19–24. doi: 10.3109/00016488409128537. [DOI] [PubMed] [Google Scholar]
  • 8.Smith A., Thomas M., Kent J., Nicholson K. Effects of the common cold on mood and performance. Psychoneuroendocrinology. 1998;23:733–739. doi: 10.1016/S0306-4530(98)00042-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Weiss R.A. Virulence and pathogenesis. Trends Microbiol. 2002;10:314–317. doi: 10.1016/S0966-842X(02)02391-0. [DOI] [PubMed] [Google Scholar]
  • 10.Eccles R. Asymptomatic spread of flu is not proved. BMJ. 2005;331:1145. doi: 10.1136/bmj.331.7525.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Turner R.B., Hendley J.O. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother. 2005;56:805–807. doi: 10.1093/jac/dki329. [DOI] [PubMed] [Google Scholar]
  • 12.Turner R.B. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78:531–539. doi: 10.1016/S1081-1206(10)63213-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hendley J.O. The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis. 1998;26:847–848. doi: 10.1086/513921. [DOI] [PubMed] [Google Scholar]
  • 14.Beutler B. Science review: Key inflammatory and stress pathways in critical illness — The central role of the Toll-like receptors. Crit Care. 2003;7:39–46. doi: 10.1186/cc1828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Exton M.S. Infection-induced anorexia: active host defence strategy. Appetite. 1997;29:369–383. doi: 10.1006/appe.1997.0116. [DOI] [PubMed] [Google Scholar]
  • 16.Eccles R. Pathophysiology of nasal symptoms. Am J Rhinol. 2000;14:335–338. doi: 10.2500/105065800781329528. [DOI] [PubMed] [Google Scholar]
  • 17.Proud D., Reynolds C.J., Lacapra S., Kagey-Sobotka A., Lichenstein L.M., Naclerio R.M. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988;173:613–616. doi: 10.1164/ajrccm/137.3.613. [DOI] [PubMed] [Google Scholar]
  • 18.Shibayama Y., Skoner D., Suehiro S., Konishi J.E., Fireman P., Kaplan A.P. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology. 1996;33:311–313. doi: 10.1016/0162-3109(96)00051-3. [DOI] [PubMed] [Google Scholar]
  • 19.Conti B., Tabarean I., Andrei C., Bartfai T. Cytokines and fever. Front Biosci. 2004;9:1433–1449. doi: 10.2741/1341. [DOI] [PubMed] [Google Scholar]
  • 20.Georgitis J.W. Nasopharyngitis, pharyngitis, and tonsillitis. Immunol Allergy Clin North Am. 1993;13:109–118. [Google Scholar]
  • 21.Rees G.L., Eccles R. Sore throat following nasal and oropharyngeal bradykinin challenge. Acta Otolaryngol. 1994;114:311–314. doi: 10.3109/00016489409126062. [DOI] [PubMed] [Google Scholar]
  • 22.Eccles R., Loose I., Jawad M., Nyman L. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med. 2003;4:118–124. doi: 10.1046/j.1526-4637.2003.03019.x. [DOI] [PubMed] [Google Scholar]
  • 23.Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther. 2006;31:309–319. doi: 10.1111/j.1365-2710.2006.00754.x. [DOI] [PubMed] [Google Scholar]
  • 24.Winther B., Gwaltney J.M., Mygind N., Turner R.B., Hendley O. Sites of rhinovirus recovery after point inoculation of the upper airway. J Am Med Assoc. 1986;256:1763–1767. doi: 10.1001/jama.256.13.1763. [DOI] [PubMed] [Google Scholar]
  • 25.Leung A.K.C., Robson W.L.M. Sneezing. J Otolaryngol. 1994;23:125–129. [PubMed] [Google Scholar]
  • 26.Mygind N, Secher C, Kirkegaard J. Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl. 1983;128:16–20. [PubMed] [Google Scholar]
  • 27.Askenasy J.J.M. The photic sneeze. Postgrad Med J. 1990;66:892–893. doi: 10.1136/pgmj.66.781.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Whitman B.W., Packer R.J. The photic sneeze: Literature review and discussion. Neurology. 1993;43:868–871. doi: 10.1212/wnl.43.5.868. [DOI] [PubMed] [Google Scholar]
  • 29.Hayden F.G., Diamond L., Wood P.B., Korts D.C., Wecker M.T. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996;125:89–97. doi: 10.7326/0003-4819-125-2-199607150-00002. [DOI] [PubMed] [Google Scholar]
  • 30.Eccles R., Vancauwenberge P., Tetzloff W., Borum P. A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate in the relief of runny nose and sneezing associated with upper respiratory-tract infection. J Pharm Pharmacol. 1995;47:990–993. doi: 10.1111/j.2042-7158.1995.tb03283.x. [DOI] [PubMed] [Google Scholar]
  • 31.Gwaltney JM, Winther B. Symposium on rhinovirus pathogenesis. Acta Otolaryngol (Stockholm) 1994;413:45p. [Google Scholar]
  • 32.Eccles R. Physiology of nasal secretion. Eur J Respir Dis. 1983;62:115–119. [Google Scholar]
  • 33.Eccles R., Pedersen A., Regberg D., Tulento H., Borum P., Stjarne P. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol. 2007;21:40–45. doi: 10.2500/ajr.2007.21.2902. [DOI] [PubMed] [Google Scholar]
  • 34.Murray S., Del Mar C., O’Rourke P. Predictors of an antibiotic prescription by GPs for respiratory tract infections: A pilot. Fam Pract. 2000;17:386–388. doi: 10.1093/fampra/17.5.386. [DOI] [PubMed] [Google Scholar]
  • 35.Stockley R.A., Bayley D., Hill S.L., Hill A.T., Crooks S., Campbell E.J. Assessment of airway neutrophils by sputum colour: Correlation with airways inflammation. Thorax. 2001;56:366–372. doi: 10.1136/thorax.56.5.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Arroll B, Kenealy T (2005) Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews (Online): CD000247 [DOI] [PubMed]
  • 37.Davis S.S., Eccles R. Nasal congestion: Mechanisms, measurement and medications. Core information for the clinician. Clin Otolaryngol. 2004;29:659–666. doi: 10.1111/j.1365-2273.2004.00885.x. [DOI] [PubMed] [Google Scholar]
  • 38.Eccles R. Nasal airflow in health and disease. Acta Otolaryngol (Stockholm) 2000;120:580–595. doi: 10.1080/000164800750000388. [DOI] [PubMed] [Google Scholar]
  • 39.Eccles R., Reilly M., Eccles K.S.J. Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol. 1996;116:77–81. doi: 10.3109/00016489609137717. [DOI] [PubMed] [Google Scholar]
  • 40.Malcolmson K.G. The vasomotor activities of the nasal mucous membrane. J Laryngol Otol. 1959;37:73–98. doi: 10.1017/s0022215100054980. [DOI] [PubMed] [Google Scholar]
  • 41.Eccles R. Sympathetic control of nasal erectile tissue. Eur J Respir Dis. 1983;64:150–154. [PubMed] [Google Scholar]
  • 42.Lacroix J.S., Stjarne P., Anggard A., Lundberg J.M. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y. Acta Physiol Scand. 1989;135:17–28. doi: 10.1111/j.1748-1716.1989.tb08546.x. [DOI] [PubMed] [Google Scholar]
  • 43.Eccles R., Eriksson M., Garreffa S., Chen S.C. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. 2008;22:491–496. doi: 10.2500/ajr.2008.22.3202. [DOI] [PubMed] [Google Scholar]
  • 44.Eccles R., Jawad M.S., Angello J.T., Druce H.M. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol. 2005;19:25–31. [PubMed] [Google Scholar]
  • 45.Clarke J.D., Eccles R. Paradoxical sensation of nasal airflow in patients with common cold. Are we measuring the correct modality? Acta Otolaryngol. 2005;125:1307–1311. doi: 10.1080/00016480510043404. [DOI] [PubMed] [Google Scholar]
  • 46.Gwaltney J.M., Phillips C.D., Miller R.D., Riker D.K. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25–30. doi: 10.1056/NEJM199401063300105. [DOI] [PubMed] [Google Scholar]
  • 47.Falck B., Svanholm H., Aust R., Backlund L. The relationship between body posture and pressure in occluded maxillary sinus of man. Rhinology. 1989;27:161–167. [PubMed] [Google Scholar]
  • 48.Whittet H.B. Infraorbital nerve dehiscence: The anatomic cause of maxillary sinus “vacuum headache”? Otolaryngol Head Neck Surg. 1992;107:21–28. doi: 10.1177/019459989210700104. [DOI] [PubMed] [Google Scholar]
  • 49.Falck B., Svanholm H., Aust R., Backlund L. Blood flow and pulse amplitude in the mucosa of the human maxillary sinus in relation to body posture. Rhinology. 1990;28:169–176. [PubMed] [Google Scholar]
  • 50.Ayub M., Thale A.B., Hedderich J., Tillmann B.N., Paulsen F.P. The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. Invest Ophthalmol Vis Sci. 2003;44:4900–4907. doi: 10.1167/iovs.03-0493. [DOI] [PubMed] [Google Scholar]
  • 51.Paulsen F., Hallmann U., Paulsen J., Thale A. Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. J Anat. 2000;197:177–187. doi: 10.1046/j.1469-7580.2000.19720177.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hadjikoutis S., Eccles R., Wiles C.M. Coughing and choking in motor neuron disease. J Neurol Neurosurg Psychiatry. 2000;68:601–604. doi: 10.1136/jnnp.68.5.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Eccles R., Lee P.C. Cough induced by airway vibration as a model of airway hyperreactivity in patients with acute upper respiratory tract infection. Pulm Pharmacol Ther. 2004;17:337–342. doi: 10.1016/j.pupt.2004.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Jacoby D.B. Pathophysiology of airway viral infections. Pulm Pharmacol Ther. 2004;17:333–336. doi: 10.1016/j.pupt.2004.09.014. [DOI] [PubMed] [Google Scholar]
  • 55.Lee P., Cotterill-Jones C., Eccles R. Voluntary control of cough. Pulm Pharmacol Ther. 2002;15:317–320. doi: 10.1006/pupt.2002.0365. [DOI] [PubMed] [Google Scholar]
  • 56.Davenport P.W. Urge-to-cough: What can it teach us about cough? Lung. 2008;186(Suppl 1):107–111. doi: 10.1007/s00408-007-9045-7. [DOI] [PubMed] [Google Scholar]
  • 57.Widdicombe J., Eccles R., Fontana G. Supramedullary influences on cough. Respir Physiol Neurobiol. 2006;152:320–328. doi: 10.1016/j.resp.2006.02.018. [DOI] [PubMed] [Google Scholar]
  • 58.Simonyan K., Saad Z.S., Loucks T.M., Poletto C.J., Ludlow C.L. Functional neuroanatomy of human voluntary cough and sniff production. Neuro Image. 2007;37:401–409. doi: 10.1016/j.neuroimage.2007.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hutchings H.A., Eccles R., Smith A.P., Jawad M. Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. Eur Respir J. 1993;6:1449–1454. [PubMed] [Google Scholar]
  • 60.Hutchings H.A., Morris S., Eccles R., Jawad M. Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respir Med. 1993;87:379–382. doi: 10.1016/0954-6111(93)90052-2. [DOI] [PubMed] [Google Scholar]
  • 61.Eccles R. Mechanisms of the placebo effect of sweet cough syrups. Respir Physiol Neurobiol. 2006;152:340–348. doi: 10.1016/j.resp.2005.10.004. [DOI] [PubMed] [Google Scholar]
  • 62.Smith R.S. The cytokine theory of headache. Med Hypotheses. 1992;39:168–174. doi: 10.1016/0306-9877(92)90181-B. [DOI] [PubMed] [Google Scholar]
  • 63.Gold R., Rieckmann P., Chang P., Abdalla J. The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple selerosis: 4-year data from the PRISMS study. Eur J Neurol. 2005;12:649–656. doi: 10.1111/j.1468-1331.2005.01083.x. [DOI] [PubMed] [Google Scholar]
  • 64.van Zonneveld M., Flink H.J., Verhey E., Senturk H., Zeuzem S., Akarca U.S., Cakaloglu Y., Simon C., So T.M., Gerken G., et al. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: Predictive factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther. 2005;21:1163–1171. doi: 10.1111/j.1365-2036.2005.02453.x. [DOI] [PubMed] [Google Scholar]
  • 65.Bo S.H., Davidsen E.M., Gulbrandsen P., Dietrichs E., Bovim G., Stovner L.J., White L.R. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. 2009;29:365–372. doi: 10.1111/j.1468-2982.2008.01727.x. [DOI] [PubMed] [Google Scholar]
  • 66.Helman C.G. Feed a cold, starve a fever”. Folk models of infection in an English suburban community, and their relation to medical treatment. Cult Med Psychiatry. 1978;2:107–137. doi: 10.1007/BF00054580. [DOI] [PubMed] [Google Scholar]
  • 67.Sanu A., Eccles R. The effects of a hot drink on nasal airflow and symptoms of common cold and flu. Rhinology. 2008;46:271–275. [PubMed] [Google Scholar]
  • 68.Guieu J.D., Hellon R.F. The chill sensation in fever. Pflugers Arch. 1980;384:103–104. doi: 10.1007/BF00589522. [DOI] [PubMed] [Google Scholar]
  • 69.Cabanac M. Phylogeny of fever. In: J B., K V., editors. Thermoreception and temperature regulation. Berlin: Springer; 1990. pp. 284–296. [Google Scholar]
  • 70.Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., Walmsley S.L., Mazzulli T., Avendano M., Derkach P., et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
  • 71.Leon L.R. Invited review: Cytokine regulation of fever: Studies using gene knockout mice. J Appl Physiol. 2002;92:2648–2655. doi: 10.1152/japplphysiol.01005.2001. [DOI] [PubMed] [Google Scholar]
  • 72.Netea M.G., Kullberg B.J., Van der Meer J.W. Circulating cytokines as mediators of fever. Clin Infect Dis. 2000;31(Suppl 5):178–184. doi: 10.1086/317513. [DOI] [PubMed] [Google Scholar]
  • 73.Blatteis C.M. The onset of fever: New insights into its mechanism. Prog Brain Res. 2007;162:3–14. doi: 10.1016/S0079-6123(06)62001-3. [DOI] [PubMed] [Google Scholar]
  • 74.Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153–160. doi: 10.1016/j.bbi.2006.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Vollmer-Conna U., Fazou C., Cameron B., Li H., Brennan C., Luck L., Davenport T., Wakefield D., Hickie I., Lloyd A. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychological Medicine. 2004;34:1289–1297. doi: 10.1017/S0033291704001953. [DOI] [PubMed] [Google Scholar]
  • 76.Herzog C., Berger R., Fernex M., Friesecke K., Havas L., Just M., Dubach U.C. What dose of intranasal interferon for the common cold? Lancet. 1986;1:1089–1090. doi: 10.1016/S0140-6736(86)91350-4. [DOI] [PubMed] [Google Scholar]
  • 77.Gwaltney J.M., Jr, Winther B., Patrie J.T., Hendley J.O. Combined antiviralantimediator treatment for the common cold. J Infect Dis. 2002;186:147–154. doi: 10.1086/341455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Schaefer M., Schmidt F., Neumer R., Scholler G., Schwarz M. Interferonalpha, cytokines and possible implications for mood disorders. Bipolar Disord. 2002;4(Suppl 1):111–113. doi: 10.1034/j.1399-5618.4.s1.52.x. [DOI] [PubMed] [Google Scholar]
  • 79.Miller A.H. Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun. 2009;23:149–158. doi: 10.1016/j.bbi.2008.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Raison C.L., Borisov A.S., Majer M., Drake D.F., Pagnoni G., Woolwine B.J., Vogt C.J., Massung B., Miller A.H. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry. 2009;65:296–303. doi: 10.1016/j.biopsych.2008.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.McCarthy D.O. Cytokines and the anorexia of infection: Potential mechanisms and treatments. Biol Res Nurs. 2000;1:287–298. doi: 10.1177/109980040000100405. [DOI] [PubMed] [Google Scholar]
  • 82.Brobeck J.R. Food intake as a mechanism of temperature regulation. Yale J Biol Med. 1948;20:545–552. [PMC free article] [PubMed] [Google Scholar]
  • 83.Mahoney T., Ball P. Common respiratory tract infections as psychological entities: A review of the mood and performance effects of being ill. Aust Psychol. 2002;37:86–94. doi: 10.1080/00050060210001706726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Baracos V., Rodemann H.P., Dinarello C.A., Goldberg A.L. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308:553–558. doi: 10.1056/NEJM198303103081002. [DOI] [PubMed] [Google Scholar]
  • 85.Kotler D.P. Cachexia. Ann Intern Med. 2000;133:622–634. doi: 10.7326/0003-4819-133-8-200010170-00015. [DOI] [PubMed] [Google Scholar]

Articles from Common Cold are provided here courtesy of Nature Publishing Group

RESOURCES